VTVT 8-K 2026-10-06

vTv Therapeutics Inc. (VTVT) 8-K dated 2026-10-06 — accession 0001641489-26-000032. This URL is the filing, not the VTVT hub.

vTv Therapeutics Inc. (VTVT) is a biotechnology company listed on NASDAQ.

vTv Therapeutics Inc. filed a 8-K on 2026-10-06. Accession 0001641489-26-000032.

Cached items: 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VTVT revenue for 2025-12-31 was $0. Net income was -$27.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. VTVT currently screens at market cap $133.9M.

Not investment advice. The VTVT SEC hub lists recent forms. The stock page is the research view.